ProShares Ultra Silver ETF vs Novartis AG — how do they compare? ProShares Ultra Silver ETF trades at $83.24, while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG pays a 3.07% dividend while ProShares Ultra Silver ETF pays none, and Novartis AG is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.
| AGQ | NVS | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $400.47 | $168.62 |
52-Week Low | $49.73 | $119.31 |
Market Cap | — | $295.37B |
Enterprise Value | — | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.
Read more on AGQ →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →